The goal of the Nuclear Magnetic Resonance (NMR) Shared Resource at the Purdue University Cancer Center is to provide essential NMR services to Cancer Center investigators. These services include providing sample analysis on nine spectrometers and expert assistance to researchers in setting up and interpreting NMR experiments. The funds requested will support this essential resource for Cancer Center members who use NMR in their research. Currently, at least 20 principal investigators with peer reviewed funding make extensive use of the Facility. Specific cancer research areas that utilize the NMR shared resource include: I) Examination of cellular processes involved in human cancer. NMR is used to obtain mechanistic and structural information about proteins and enzymes involved in cell transformation. 2) Studies of the mechanisms of action of anticancer drugs. 3) Development of synthetic routes to known and new anti-cancer agents. NMR is an absolute requirement for the synthetic and drug discovery programs targeted to increase the supply of known anticancer compounds as well as -to devise new compounds. NMR is used to monitor the course of reactions and to determine the structure of these complex synthetic molecules. The NMR Shared Resource provides state of the art NMR equipment and services for cancer researchers at Purdue University. This Facility is critical for the successful completion of many diverse cancer-related research projects and provides a necessary service in efforts to understand and treat cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Purdue University
West Lafayette
United States
Zip Code
Lee, Hyeon Jeong; Li, Jie; Vickman, Renee E et al. (2018) Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/?-catenin Pathway. Mol Cancer Res 16:974-985
Bhandari, Pushpak; Novikova, Gloriia; Goergen, Craig J et al. (2018) Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy. Sci Rep 8:3112
Dhawan, Deepika; Hahn, Noah M; Ramos-Vara, José A et al. (2018) Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer. PLoS Genet 14:e1007571
Shinde, Aparna; Libring, Sarah; Alpsoy, Aktan et al. (2018) Autocrine Fibronectin Inhibits Breast Cancer Metastasis. Mol Cancer Res 16:1579-1589
Ghosh, Arun K; Ghosh, Koena; Brindisi, Margherita et al. (2018) Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand. Bioorg Med Chem Lett 28:2605-2610
Thompson, Taylor J; Han, Bumsoo (2018) Analysis of adhesion kinetics of cancer cells on inflamed endothelium using a microfluidic platform. Biomicrofluidics 12:042215
Alpsoy, Aktan; Dykhuizen, Emily C (2018) Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes. J Biol Chem 293:3892-3903
Kumari, Rashmi; Silic, Martin R; Jones-Hall, Yava L et al. (2018) Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors. Oncotarget 9:23494-23504
Larocque, Elizabeth A; Naganna, N; Opoku-Temeng, Clement et al. (2018) Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase. ChemMedChem 13:1172-1180
VerHeul, Ross; Sweet, Craig; Thompson, David H (2018) Rapid and simple purification of elastin-like polypeptides directly from whole cells and cell lysates by organic solvent extraction. Biomater Sci 6:863-876

Showing the most recent 10 out of 436 publications